Summary

The Minimally Invasive Technology Role and Evaluation [MITRE] Study, a randomized controlled trial of continuous glucose monitoring device use, showed them to be of no greater benefit than standard care. This article discusses the report that all groups, including controls, had a sustained reduction of HbA1C.